During a system upgrade from Friday, Dec. 5, through Sunday, Dec. 7, the AAFP website, on-demand courses and CME purchases will be unavailable.

brand logo

Am Fam Physician. 2025;112(3):328-329

Author disclosure: No relevant financial relationships.

CLINICAL QUESTION

Are oral prostaglandins as safe and effective as oxytocin for induction of labor in pregnant patients with rupture of membranes at term but before labor onset (ie, premature rupture of membranes [PROM])?

EVIDENCE-BASED ANSWER

In pregnant patients with PROM, oral prostaglandins (eg, misoprostol) are as effective as intravenous (IV) oxytocin infusion for achieving vaginal delivery within 24 hours of initiation. (Strength of Recommendation [SOR]: A, meta-analyses of randomized controlled trials [RCTs] and subsequent RCTs.) Use of oral misoprostol is associated with similar risks of uterine hyperstimulation, tachysystole, need for cesarean delivery, and meconium-stained amniotic fluid as use of IV oxytocin. (SOR: A, meta-analysis of RCTs.)

EVIDENCE SUMMARY

A 2014 systematic review and meta-analysis broadly assessed use of oral misoprostol for labor induction in the third trimester. A subgroup analysis compared oral misoprostol with oxytocin in pregnant patients with PROM. Patients in this group were predominantly nulliparous with initial Bishop scores of 4.5 to 6.0. Trials were conducted in a variety of predominantly tertiary care settings in multiple countries. Misoprostol regimens varied, with most dosages between 50 and 100 mcg every 4 or 6 hours.1

Already a member/subscriber?  Log In

Subscribe

From $180
  • Immediate, unlimited access to all AFP content
  • More than 125 CME credits/year
  • AAFP app access
  • Print delivery available
Subscribe

Issue Access

$59.95
  • Immediate, unlimited access to this issue's content
  • CME credits
  • AAFP app access
  • Print delivery available
Interested in AAFP membership?  Learn More

Clinical Inquiries provides answers to questions submitted by practicing family physicians to the Family Physicians Inquiries Network (FPIN). Members of the network select questions based on their relevance to family medicine. Answers are drawn from an approved set of evidence-based resources and undergo peer review. The strength of recommendations and the level of evidence for individual studies are rated using criteria developed by the Evidence-Based Medicine Working Group (https://www.cebm.net).

The complete database of evidence-based questions and answers is copyrighted by FPIN. If interested in submitting questions or writing answers for this series, go to https://www.fpin.org or email questions@fpin.org.

Copyright © Family Physicians Inquiries Network. Used with permission.

This series is coordinated by John E. Delzell Jr., MD, MSPH, associate medical editor.

A collection of FPIN’s Clinical Inquiries published in AFP is available at https://www.aafp.org/afp/fpin.

Continue Reading

More in AFP

More in PubMed

Copyright © 2025 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.